Position in ARGX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$10,558,022
+$8,936,867 QoQ
Shares Held
11,380
+412.6% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#119
of 507 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AustralianSuper Pty Ltd holds $157,332,349 across 6 Biotechnology names. ARGX ranks #2 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,196,491 | $135,634,219 | |
| 2 | ARGX |
Argenx SE
This page
|
11,380 | $10,558,022 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
30,335 | $7,425,097 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,032 | $1,506,085 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,803 | $1,445,847 | |
| 6 | INSM |
INSMED Inc
|
7,157 | $763,079 |
All Filings in ARGX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,558,022 | 11,380 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,621,155 | 2,220 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,112,576 | 1,323 | Shares | Sole | 2026-02-05 | |
| No filing history on record for this holder in this stock. | ||||||